Jiangsu Hengrui Pharma is a Chinese pharmaceutical company based in Lianyungang that researches, develops and makes medicines. Its main areas are oncology, anaesthesia and contrast agents for medical imaging, and it offers both innovative drugs and generic products. The company supplies hospitals and healthcare providers, chiefly in China, and also works with partners abroad to bring its medicines to other markets. Its portfolio includes small-molecule drugs and biologic treatments developed through its own research programmes.
Jiangsu Hengrui Pharma Co Ltd trades under the code 1276 on the Hong Kong Stock Exchange in Hong Kong, with its price quoted in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #1496 of 2611 on the Hong Kong Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Hong Kong yet.
TrendWeak
37/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-17.4%
From 52-week high-39.9%
MomentumWeak
28/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-13.8%
6-month return-26.6%
12-month, skipping last month-44.9%
Stability (higher is calmer)Fair
61/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)40.9%
Worst drawdown, 1 year (smaller is calmer)-47.0%
LiquidityStrong
95/100
Trades actively.
See the numbers →
Avg daily value traded249.56M HKD
Zero-volume days0.0%
IncomeWeak
2/100
Dividend is small or irregular.
See the numbers →
Dividend yield0.5%
Years with dividends1
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Hong Kong when fundamentals data for this market is added. All Hong Kong stocks.
52-wk range 43.02 – 84.80Daily closes, split-adjusted
Signals
50-day average48.07
200-day average60.04
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2.06
Technical summary
Daily
Neutral
7 bullish · 3 neutral · 5 bearish
Weekly
Bearish
2 bullish · 1 neutral · 5 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 2 bearish
Moving averages (daily)
SMA 10
48.06
Bullish
EMA 10
48.20
Bullish
SMA 20
47.64
Bullish
EMA 20
47.85
Bullish
SMA 50
48.07
Bullish
EMA 50
49.08
Bullish
SMA 100
52.44
Bearish
EMA 100
52.54
Bearish
SMA 200
60.04
Bearish
EMA 200
–
n/a
Oscillators (daily)
RSI (14)
56.61
Neutral
MACD (12, 26)
0.20
Bullish
Momentum (12)
-0.16
Bearish
Stochastic %K (14)
74.73
Neutral
Williams %R (14)
-25.27
Neutral
CCI (20)
134.1
Bearish
Pivot points (classic, last session)
S3
47.65
S2
48.55
S1
49.06
Pivot
49.96
R1
50.47
R2
51.37
R3
51.88
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.23 HKD
Yield on today's price
0.46%
Frequency
Annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
0.2283
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in HKD. Educational only, not financial advice.
